US Patent Issued to National University of Singapore, Nkarta on July 8 for "Immune cells comprising truncated NKG2D chimeric receptors" (Singaporean, British, American Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,617, issued on July 8, was assigned to National University of Singapore (Singapore) and Nkarta Inc. (South San Francisco, Calif.).

"Immune cells comprising truncated NKG2D chimeric receptors" was invented by Jun Hao Leong (Singapore), Noriko Shimasaki (Singapore), See Voon Seow (Singapore), Dario Campana (Singapore), James Barnaby Trager (Albany, Calif.), Alexandra Leida Liana Lazetic (San Jose, Calif.), Chao Guo (San Francisco), Luxuan Guo Buren (San Francisco) and Shyam Sashikant Masrani (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Several embodiments disclosed herein relate to the compositions comprising engineered Natural Killer (NK) ce...